(Total Views: 510)
Posted On: 06/12/2022 7:11:21 AM
Post# of 156478
Quote
“ There are 1.2 million hiv positive people in the USA. Ccr5 tropism hiv is about 70% of that, 840,000 total. If leronlimab treats just 10% of that population, at about $40k a year we are at $3.3 billion a year in revenue. That is only 10% of the market in the USA. I don’t think that is small.””
Unfortunately our trial was for MDR or multi drug resistant patients which would not include all patients just those who failed with multiple other treatments.
Of course drugs can be prescribed off label but the potential based in the label is much smaller than you claim
IMO
“ There are 1.2 million hiv positive people in the USA. Ccr5 tropism hiv is about 70% of that, 840,000 total. If leronlimab treats just 10% of that population, at about $40k a year we are at $3.3 billion a year in revenue. That is only 10% of the market in the USA. I don’t think that is small.””
Unfortunately our trial was for MDR or multi drug resistant patients which would not include all patients just those who failed with multiple other treatments.
Of course drugs can be prescribed off label but the potential based in the label is much smaller than you claim
IMO
(0)
(0)
